Litcius/Paper detail

Role of IL-17 and IL-23 in the Pathogenesis of Neutrophilic Asthma

Nightingale Syabbalo

2020International Journal of Immunology and Immunotherapy9 citationsDOIOpen Access PDF

Abstract

Asthma is a complex chronic airway disease with several distinct phenotypes characterized by different immunopathological pathways, clinical presentation, physiology, comorbidities, biomarker of allergic inflammation, and response to treatment. Approximately 10% of patients with asthma have severe refractory disease, which is difficult to control on high doses of inhaled corticosteroids and other modifiers. About 50% of these individuals suffer from neutrophilic asthma.

Topics & Concepts

AsthmaPathogenesisMedicineBiomarkerImmunologyInflammationDiseaseAirwayRefractory (planetary science)Internal medicineBiologyAstrobiologyBiochemistrySurgeryAsthma and respiratory diseasesPediatric health and respiratory diseases
Role of IL-17 and IL-23 in the Pathogenesis of Neutrophilic Asthma | Litcius